Commentary: We've only just begun: unravelling the underlying genetics of neurodevelopmental disorders - a commentary on Kiser et al. (2015)

Grants

Funding Acknowledgements

D.C. has disclosed interests in relation to his role as one of the joint editors of JCPP as below, but has no specific competing or potential conflicts of interest in relation to this article. D.C.: Advisory board membership for Cephalon, Eli Lilly, Janssen Cilag, Pfizer, Shire and UCB; consultancy for Shire; research funding support from Shire, Eli Lilly and Janssen Cilag.